FDA Inspection 1246877 — Gulf Coast Regional Blood Center At Westchase
The FDA completed an inspection of Gulf Coast Regional Blood Center At Westchase on Sep 12, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)